Sugi Predict

Sugi Predict / Compounds / SCHEMBL31151473

SCHEMBL31151473

SCHEMBL31151473

CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ OPRD1 P41143 4/20 0.61
▸ F2 P00734 1/20 0.61
▸ OPRM1 P35372 1/20 0.61
▸ OPRK1 P41145 1/20 0.61
▸ SLC6A2 P23975 1/20 0.60
▸ AGTR2 P50052 5/20 0.59
▸ AGTR1 P30556 4/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30361896 0.95 NTSR1 (0.61) OPRD1OPRM1OPRK1AGTR2AGTR1
SCHEMBL31151446 0.95 NTSR1 (0.59) OPRD1F2OPRM1OPRK1AGTR2
SCHEMBL29414469 0.94 NTSR1 (0.62) OPRD1OPRM1OPRK1
SCHEMBL31151670 0.94 NTSR1 (0.60) OPRD1F2
SCHEMBL30361786 0.92 NTSR1 (0.61) OPRD1OPRM1OPRK1AGTR2AGTR1
SCHEMBL30361957 0.92 NTSR1 (0.60) OPRD1OPRM1OPRK1AGTR2AGTR1
SCHEMBL29894426 0.92 NTSR1 (0.63) OPRD1F2OPRM1OPRK1AGTR2
SCHEMBL30623611 0.92 NTSR1 (0.65) OPRD1OPRM1OPRK1
SCHEMBL30294171 0.92 NTSR1 (0.64) OPRD1OPRM1OPRK1
SCHEMBL31151633 0.91 NTSR1 (0.61) OPRD1OPRM1OPRK1AGTR2AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4713002-A1 PEPTIDES FOR USE IN THE TREATMENT OF SARCOMA Forssmann, Wolf-Georg (DE) 2026-03-25 — — EP disclosed
EP-4501347-A1 PEPTIDES FOR USE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS Forssmann, Wolf-Georg (DE) 2025-02-05 — — EP disclosed
EP-4501348-A1 PEPTIDES FOR USE IN THE IMPROVEMENT OF WELL-BEING Forssmann, Wolf-Georg (DE) 2025-02-05 — — EP disclosed
WO-2024235986-A1 PEPTIDES FOR USE IN THE TREATMENT OF SARCOMA PHARIS BIOTEC GMBH (DE) 2024-11-21 — — WO disclosed
Send feedback